• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING Back to Search Results
Model Number 24653
Device Problems Difficult to Advance (2920); Activation Failure (3270)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/03/2023
Event Type  Injury  
Event Description
It was reported that the stent failed to fully expand, and the radial force was insufficient to treat the target lesion.An additional stent was required to adequately treat the target lesion.An eluvia drug-eluting vascular stent system 6x120, 130cm was selected for use in the superficial femoral artery (sfa).The target lesion was 100% stenosed with severe calcification and tortuosity.The target lesion was approached contralaterally using a non-boston scientific guidewire and an unknown guide sheath.When the eluvia delivery system passed through the common iliac bifurcation, there was difficulty advancing.Once at the target lesion, the eluvia stent was deployed without difficulty.Once the stent was deployed, the physician determined that the stent failed to expand fully, and that the radial force was insufficient to treat the target lesion.An additional eluvia stent was required to adequately treat the target lesion.The procedure was completed, and there were no reported adverse consequences for the patient.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key17647724
MDR Text Key322241418
Report Number2124215-2023-46600
Device Sequence Number1
Product Code NIU
Combination Product (y/n)Y
Reporter Country CodeKS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 08/29/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/29/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/24/2024
Device Model Number24653
Device Catalogue Number24653
Device Lot Number0029046063
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/03/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/24/2022
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Treatment
ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM
Patient Outcome(s) Required Intervention;
Patient Age66 YR
Patient SexFemale
-
-